Nasal Symptoms Reduction and Decreased Neutrophilia in Japanese Cedar Pollinosis With Prophylactic Treatment With a Combination of Montelukast,Fexofenadine,and Fluticasone Nasal Spray

Abstract

Background and Objective

We reported neutrophil-associated tissue damage in cedar pollinosis subjects with refractory nasal symptoms prior to pollinosis season. Because the leukotriene receptor antagonist, montelukast, can inhibit neutrophil recruitment and activation, we investigated its effects on symptom relief and nasal neutrophilia in pollinosis subjects in the preseason.

Methods

In the pollinosis preseason, symptomatic (PreSyP, n = 149) and asymptomatic subjects (PreAsP, n = 145) were prophylactically treated, and in season symptomatic subjects (InSyP, n = 134) were treated. Individuals were assigned to 1 of 2 treatment protocols: administration of cetirizine and fluticasone nasal spray (Cet-Flu) or montelukast, fexofenadine, and fluticasone nasal spray (Mo-Fex-Flu). Differences in symptom relief and inflammatory cell infiltration in nasal swabs were investigated.

Results

In pollen season, 59% of PreSyP subjects given Cet-Flu and 88% of those treated with Mo-Fex-Flu had none or mild symptoms (P < .00001). In PreAsP subjects in season, 71% of Cet-Flu and 98% of Mo-Fex-Flu recipients had none to mild symptoms (P < .0000001). The proportions of subjects in the PreSyP group with nasal swabs with neutrophils 1+ to 3+ before and after treatment by Mo-Fex-Flu were 59% and 18%, respectively (P < .0001), and in PreAsyP, subjects with neutrophils 2+ to 3+ were 17% and 5%, respectively (P = .034). In PreSyP, a significant reduction in the percentage of subjects with mast cells >1+ was seen following both Cet-Flu (P = .027) and Mo-Fex-Flu (P = .0014) treatments.

Conclusion

In PreSyP and PreAsP subjects, treatments with Mo-Fex-Flu were more effective than Cet-Flu to reduce nasal symptom scores. These effects were associated with reduction in the number of neutrophils and mast cells in nasal swabs.

Keywords

Japanese cedar pollinosis neutrophil montelukast fexofenadine fluticasone nasal spray cetirizine prophylactic treatment eosinophil mast cell

Get full access to this article

View all access options for this article.

References

Okubo

Kurono

Ichimura

et al . Japanese Society of Allergology. Japanese guidelines for allergic rhinitis. Allergol Int. 2017; 66:205–219.

Otsuka

Takanashi

Okubo

Analysis of cytology in nasal smear of Japanese cedar pollinosis before and in season. Arerugi. 2012; 61:1092–1103. [Article in Japanese]

Otsuka

Takanashi

Tokunou

et al . Involvement of Staphylococcus aureus and Moraxella catarrhalis in Japanese cedar pollinosis. Am J Rhinol Allergy. 2016; 30:99–106.

Anderson

Theron

Gravett

et al . Montelukast inhibits neutrophil pro-inflammatory activity by a cyclic AMP-dependent mechanism. Br J Pharmacol. 2009; 156:105–115.

Gravett

Theron

Steel

et al . Interactive inhibitory effects of formoterol and montelukast on activated human neutrophils. Eur Respir J. 2010; 36:1417–1424.

Al-Amran

Hadi

Hachim

AM.

Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats.

Eur J Cardiothorac Surg. 2013; 43:421–427.

Tintinger

Feldman

Theron

et al . Montelukast: more than a cysteinyl leukotriene receptor antagonist? ScientificWorld J. 2010; 10:2403–2413.

Durham

OC.

The volumetric incidence of atmospheric allergens. IV. A proposed standard method of gravity sampling, counting, and volumetric interpolation of results.

J Allergy. 1946; 17:79–86.

Kakutani

Ogino

Ikeda

et al . Comparison of clinical efficacy and cost-quality of antihistamines in early treatment for Japanese cedar pollinosis. Arerugi. 2006; 55:554–565. [Article in Japanese].

10.

Conboy-Ellis

Management of seasonal allergic rhinitis: comparative efficacy of the newer-generation prescription antihistamines.

J Am Acad Nurse Pract. 2005; 17:295–301.

11.

Spangler

Brunton

Efficacy and central nervous system impairment of newer-generation prescription antihistamines in seasonal allergic rhinitis.

South Med J. 2006; 99:593–599.

12.

Day

Briscoe

Rafeiro

et al . Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit. Allergy Asthma Proc. 2005; 26:275–282.

13.

Hansel

FK.

Clinical Allergy. St. Louis, MO: Mosby; 1953:408–418.

14.

Otsuka

Okuda

Takahashi

et al . Quantification of eosinophilia in allergic nasal secretions. Jibirinsho. 1978; 71:445–451. [Article in Japanese].

15.

Özgür

Arslanoğlu

Etıt

et al . Comparison of nasal cytology and symptom scores in patients with seasonal allergic rhinitis, before and after treatment. J Laryngol Otol. 2011; 125:1028–1032.

16.

Suzuki

Shimomura

Ikeda

et al . Effects of long-term low-dose macrolide administration on neutrophil recruitment and IL-8 in the nasal discharge of chronic sinusitis patients. Tohoku J Exp Med. 1997; 182:115–124.

17.

Yamada

Saito

Fujieda

Present state of Japanese cedar pollinosis: the national affliction.

J Allergy Clin Immunol. 2014; 133:632–639.

18.

Fujieda

Kurono

Okubo

et al . Examination, diagnosis and classification for Japanese allergic rhinitis: Japanese guideline. Auris Nasus Larynx. 2012; 39:553–556.

19.

Bureau of Social Welfare and Public Health, Tokyo Metropolitan Government. Japanese Cedar Pollinosis Survey Report in Tokyo 2016. 4th: 1–63, 2017. [in Japanese].

20.

Bousquet

Khaltaev

Cruz

et al . Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008; 63 Suppl 86:8–160.

21.

Yonekura

Okamoto

Yamamoto

et al . Randomized double-blind study of prophylactic treatment with an antihistamine for seasonal allergic rhinitis. Int Arch Allergy Immunol. 2013; 162:71–78.

22.

Higaki

Okano

Makihara

et al . Early interventional treatment with intranasal corticosteroids compared with postonset treatment in pollinosis. Ann Allergy Asthma Immunol. 2012; 109:458–464.

23.

Takahashi

Matsuzaki

Okamoto

et al . A randomized control trail of stepwise treatment with fluticasone propionate nasal spray and fexofenadine hydrochloride tablet for seasonal allergic rhinitis. Allergol Int. 2012; 61:155–162.

24.

Yamamoto

Yonekura

Sakurai

et al . Comparison of nasal steroid with antihistamine in prophylactic treatment against pollinosis using an environmental challenge chamber. Allergy Asthma Proc. 2012; 33:397–403.

25.

Otsuka

Tsukagoshi

Kimura

et al . Are respiratory viruses involved in preseasonal symptoms or severity in Japanese cedar pollinosis? Allergy Rhinol. 2016; 7:62–78.

26.

Glück

Gebbers

JO.

Local pathogenic bacteria in allergic rhinitis: a novel concept of its pathogenesis.

ORL J Otorhinolaryngol Relat Spec. 2003; 65:202–205.

27.

Choi

Poroyko

Watanabe

et al . Seasonal allergic rhinitis affects sinonasal microbiota. Am J Rhinol Allergy. 2014; 28:281–286.

28.

Zemans

Colgan

Downey

GP.

Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury.

Am J Respir Cell Mol Biol. 2009; 40:519–535.

29.

Fischer

Zheng

Fan

et al . Neutrophil elastase inhibition of cell cycle progression in airway epithelial cells in vitro is mediated by p27kip1. Am J Physiol Lung Cell Mol Physiol. 2007; 293:762–768.

30.

Knaapen

Schins

Polat

et al . Mechanisms of neutrophil-induced DNA damage in respiratory tract epithelial cells. Mol Cell Biochem. 2002; 234–235(1–2):143–151.

31.

Fink

Mathaba

Stewart

et al . Moraxella catarrhalis stimulates the release of proinflammatory cytokines and prostaglandin E from human respiratory epithelial cells and monocyte-derived macrophages. FEMS Immunol Med Microbiol. 2006; 46:198–208.

32.

Martin

Cicutto

Smith

et al . Airways inflammation in nocturnal asthma. Am Rev Respir Dis. 1991; 143:351–357.

33.

Lamblin

Gosset

Tillie-Leblond

et al . Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am J Respir Crit Care Med. 1998; 157:394–402.

34.

Sampson

AP.

The role of eosinophils and neutrophils in inflammation. Clin Exp Allergy. 2000; 30:22–27.

35.

Ray

Kolls

JK.

Neutrophilic inflammation in asthma and association with disease severity.

Trends Immunol. 2017; 38:942–954.